We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
| $10.2M | 0.07% |
+107,475
| New | +$9.89M |
|
|
GRFS
277
Grifois
GRFS
$5.16B
| $10.2M | 0.07% |
558,683
-457,603
| -45% | -$9.08M |
|
278
Sportsman's Warehouse
SPWH
$43.7M
| $10.1M | 0.07% |
710,554
-111,903
| -14% | -$1.05M |
|
|
ESPR
279
CALL
DELISTED
Esperion Therapeutics
ESPR
| $10.1M | 0.07% |
+300,000
| New | +$12.6M |
|
280
Fabrinet
FN
$17.1B
| $10.1M | 0.07% |
+161,156
| New | +$9.88M |
|
281
Angi Inc
ANGI
$224M
| $10M | 0.07% |
82,658
-43,124
| -34% | -$3.93M |
|
282
Supernus Pharmaceuticals
SUPN
$2.68B
| $10M | 0.07% |
421,100
+139,931
| +50% | +$3.09M |
|
283
Enbridge
ENB
$124B
| $9.98M | 0.07% |
329,041
+315,934
| +2,410% | +$9.71M |
|
284
Deutsche Bank
DB
$66.3B
| $9.96M | 0.07% |
1,048,141
-971,774
| -48% | -$7.53M |
|
285
Lithia Motors
LAD
$7.78B
| $9.93M | 0.07% |
+65,617
| New | +$7.51M |
|
286
Morgan Stanley
MS
$337B
| $9.9M | 0.07% |
205,017
-150,137
| -42% | -$6.31M |
|
287
BioMarin Pharmaceuticals
BMRN
$11.5B
| $9.9M | 0.07% |
80,261
+69,015
| +614% | +$6.86M |
|
|
CEO
288
DELISTED
CNOOC Limited
CEO
| $9.87M | 0.07% |
87,429
+39,455
| +82% | +$4.45M |
|
289
Fastenal
FAST
$54B
| $9.84M | 0.07% |
459,344
+206,966
| +82% | +$3.96M |
|
290
Allegion
ALLE
$13B
| $9.75M | 0.07% |
95,332
+95,007
| +29,233% | +$9.37M |
|
291
Acadia Pharmaceuticals
ACAD
$4.25B
| $9.7M | 0.07% |
+200,126
| New | +$9.61M |
|
292
UDR
UDR
$12.9B
| $9.69M | 0.07% |
259,259
+258,497
| +33,923% | +$9.65M |
|
293
Valmont Industries
VMI
$9.44B
| $9.65M | 0.07% |
84,955
+83,773
| +7,087% | +$9.3M |
|
294
Graham Holdings Company
GHC
$4.97B
| $9.64M | 0.07% |
28,127
-2,400
| -8% | -$844K |
|
|
DLPH
295
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $9.63M | 0.07% |
+677,337
| New | +$7.6M |
|
296
Schrodinger
SDGR
$1.12B
| $9.53M | 0.07% |
+104,048
| New | +$6.06M |
|
297
Ollie's Bargain Outlet
OLLI
$4.01B
| $9.51M | 0.07% |
97,429
+65,704
| +207% | +$5.05M |
|
298
Insulet
PODD
$11.3B
| $9.42M | 0.07% |
48,468
-8,973
| -16% | -$1.72M |
|
299
Allegiant Air
ALGT
$2.64B
| $9.39M | 0.07% |
86,005
-132,894
| -61% | -$12.1M |
|
|
GHIVU
300
DELISTED
Gores Holdings IV, Inc. Unit
GHIVU
| $9.36M | 0.07% |
900,000
| – | – |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.